No abstract available
MeSH terms
-
Antineoplastic Agents, Immunological* / adverse effects
-
Humans
-
Lung Neoplasms* / drug therapy
-
Lung Neoplasms* / pathology
-
Mesothelioma, Malignant*
-
Nivolumab / therapeutic use
Substances
-
Antineoplastic Agents, Immunological
-
Nivolumab